Prevention of atherosclerosis progression in asymptomatic healthy elderly

American Journal of Clinical Nutrition

Volumn 86, Issue 5, 2007, Pages

  Lees, Robert S ^a,b,c  

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Antithrombotic drugs; Blood lipids; Carotid ultrasound; Cholesterol lowering drugs; HDL raising drugs; Plaque regression

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; CLOPIDOGREL; WARFARIN;

APHERESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; DISEASE COURSE; ELDERLY CARE; HUMAN; PROPHYLAXIS;

EID: 36248955623     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.5.1569s     Document Type: Conference Paper

References (14)

1. Lees RS, Lees AM. Therapy of the hyperlipidemias. Postgrad Med 1976;60:99-107.
2. Lees RS. Impact of dietary fat on human health. In: Lees RS, Karel M, eds. Omega-3 fatty acids in health and disease. New York, NY: Dekker Inc, 1990.
3. Weiner BH, Ockene IS, Levine PH, et al. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med 1986;315:841-6.
4. Blankenhorn DH, Johnson RL, Mack WJ, et al. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990;263:1646-52.
5. Matthan NR, Welty FK, Barrett PHR, et al. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol 1004;24:1092-7.
6. Barber FE, Baker DW, Nation AW, Strandness DE Jr, Reid JM. Ultrasonic duplex echo-Doppler scanner. IEEE Trans Biomed Eng 1974;21:109-13.
7. Lo J, Dolan SE, Kanter JR, et al. Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 2006;91:1677-82.
8. Walsh JM, Grady D. Treatment of hyperlipidemia in women. JAMA 1995;274:1152-8.
9. Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 1995;75:455-9.
10. Rubin HB, Robins SJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410-8.
11. Zambon A, Hokanson JE, Brown BG, et al. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 1999;15:1959-64.
12. Miller A, Lees RS. Simultaneous therapy with antiplatelet and anticoagulant drugs in symptomatic cardiovascular disease. Stroke 1985;16:668-75.
13. Lees RS, Kistler JP, Sanders D. Duplex doppler scanning and spectral bruit analysis for diagnosing carotid stenosis. Circulation 1982;66(suppl 1):102-5.
14. Pitt B, Mancini GBJ, Ellis SG, Rosman HS, Park JS, McGovern ME, for the PLAC I Investigators. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. J Am Coll Cardio 1995;26:1133-9.